Entelos
Curated by SignalIn-silico modeling and drug discovery simulation software company
Overview
Entelos is an in-silico modeling and simulation software company providing predictive biosimulation for drug discovery and development. Italso provides advanced predictive technologies that lower the risk, time, and cost of product development in the pharmaceutical, healthcare, nutrition and consumer markets. Offers PhysioLab platforms, for highly predictive analyses to assist customers develop safer and more effective drugs, foods and consumer products. Solutions include - Target Selection, Biomarker Selection, Inter-species Translation, Patient Stratification and Trial Design. Claim that their understanding of the drivers of patient variability has significant application to the emerging field of personalized medicine. Enable scientific discovery and development organizations to transform decision support and risk assessment in target selection, species translation, biomarker identification and selection, trial design and patient stratification by providing qualitative and quantitative insights, understanding and prediction through strategic partnerships, in-depth systems biology mapping and biosimulation software.
Key facts
- Founded
- 1996
- Headquarters
- San Mateo, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 5 products and services
- Sign up to view
Contact
- Sign up to view